GC
RIGL icon

Globeflex Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Globeflex Capital’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.89M Hold
217,839
– – 0.89% 32
2025
Q4 		$9.33M Buy
217,839
+209
+0.1% +$7.88K 1.43% 7
2025
Q3 		$6.17M Buy
217,630
+50,115
+30% +$1.5M 0.95% 24
2025
Q2 		$3.14M Buy
167,515
+115,220
+220% +$2.18M 0.26% 95
2025
Q1 		$941K Hold
52,295
– – 0.09% 174
2024
Q4 		$880K Buy
52,295
+43,095
+468% +$827K 0.07% 203
2024
Q3 		$149K Buy
+9,200
New +$108K 0.01% 341
2016
Q3 		– Sell
-33,953
Closed -$757K – 536
2016
Q2 		$757K Sell
33,953
-11,000
-24% -$274K 0.21% 186
2016
Q1 		$935K Buy
+44,953
New +$1.11M 0.25% 142

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return